A novel treatment stratification system for current low- and intermediate-risk neuroblastoma patients using gene expression-based classification
Carolina Sterz(University of Cologne), Manuel Fischer(University of Basel), Dilafruz Juraeva(Merck KGaA, Darmstadt (Germany)), Benedikt Brors(German Cancer Research Center), André Oberthuer, B Hero(University of Cologne), Andreas Faldum(University of Münster), René Schmidt(University of Münster), Frank Berthold(University of Cologne)
Cited by 0
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
|New England Journal of Medicine|2020|879
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
|Nature Genetics|2020|790